Literature DB >> 6459894

Lymphocyte suppressor cell activity in acute and chronic liver disease.

T Kashio, R Hotta, S Kakumu.   

Abstract

We investigated lymphocyte suppressor cell activity in 53 patients with acute and chronic liver diseases. Suppressor cells were generated by preincubation of peripheral blood mononuclear cells (PBM) with concanavalin A (Con A) for 48 hr. Suppressor cell activity was evaluated by inhibition of Con A-stimulated blast transformation and by inhibition of pokeweed mitogen-induced immunoglobulin (Ig) synthesis of fresh allogeneic normal PBM in the second-set cultures. Of 29 patients with chronic active liver diseases (CALD), defective suppressor cell activities were observed in eight cases (28%) for Ig synthesis and 16 cases (55%) for blast transformation study. The suppressor cell activities were decreased in two (22%) of nine cases with chronic persistent hepatitis and one (17%) of six cases with inactive cirrhosis for both Ig synthesis and blast transformation. In contrast, suppressor activities were inducible in all nine patients with acute viral hepatitis. The histocompatibility antigen DR4 was significantly increased in CALD patients, but there was no correlation between this antigen and suppressor cell activity. These findings suggest that altered lymphocyte suppressor cells in patients with CALD may contribute to the continuing liver cell injury in this disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6459894      PMCID: PMC1537319     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Decreased suppressor cell activity in inflammatory bowel disease.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

3.  Alteration in suppressor cell activity in chronic active hepatitis.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

4.  Activation of human B lymphocytes. X. Heterogeneity of concanavalin A-generated suppressor cells of the pokeweed mitogen-induced plaque-forming cell response of human peripheral blood lymphocytes.

Authors:  B F Haynes; A S Fauci
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

5.  Separation of T and B lymphocytes by nylon wool columns: evaluation of efficacy by functional assays in vivo.

Authors:  D Trizio; G Cudkowicz
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

6.  Association of autoimmune active chronic hepatitis with HL-A1,8.

Authors:  I R Mackay; P J Morris
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

7.  Induction of suppressor T cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium.

Authors:  S Horowitz; W Borcherding; A V Moorthy; R Chesney; H Schulte-Wisserman; R Hong
Journal:  Science       Date:  1977-09-02       Impact factor: 47.728

8.  Suppressor thymus-derived lymphocytes in fungal infection.

Authors:  J D Stobo; S Paul; R E Van Scoy; P E Hermans
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

9.  Peripheral blood lymphocyte populations in chronic liver disease.

Authors:  H C Thomas; M Freni; J Sanchez-Tapias; D de Villiers; S Jain; S Sherlock
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Cellular mechanisms of hepatocyte damage and regulatory mechanisms in autoimmune chronic active hepatitis.

Authors:  S Vento; A L Eddleston
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Evidence of impaired antigen non-specific but normal antigen specific suppressor cell function in children with autoimmune chronic active hepatitis.

Authors:  A Lobo-Yeo; G Mieli-Vergani; G Kenna; A P Mowat; D Vergani
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

3.  Anti-lymphocytic antibodies in autoimmune chronic active hepatitis starting in childhood.

Authors:  P T Donaldson; M J Hussain; G Mieli-Vergani; A P Mowat; D Vergani
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

Review 4.  Immunological aspects of chronic active hepatitis.

Authors:  S Vento; A L Eddleston
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

Review 5.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

6.  Loss of suppressor T cell function and circulating immune complexes in chronic active liver diseases.

Authors:  R Hotta; J Kuriki; S Kakumu
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

7.  Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH).

Authors:  L S Si; T L Whiteside; R R Schade; D H Van Thiel
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

8.  Increased peripheral blood Ia positive T cells and their effect on autologous mixed lymphocyte reaction in chronic active liver disease.

Authors:  K Fukui; S Kakumu; H Murakami; J Kuriki; K Yoshioka; N Sakamoto
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

9.  Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.

Authors:  K Yoshioka; S Kakumu; H Murakami; K Fukui
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

10.  IgG production in 'autoimmune' chronic active hepatitis. Effect of prednisolone on T and B lymphocyte function.

Authors:  K T Nouri-Aria; J E Hegarty; G J Alexander; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.